559 lines
12 KiB
YAML
559 lines
12 KiB
YAML
dashboard_title: COVID Vaccine Dashboard
|
|
description: null
|
|
css: ''
|
|
slug: null
|
|
certified_by: ''
|
|
certification_details: ''
|
|
published: true
|
|
uuid: f4065089-110a-41fa-8dd7-9ce98a65e250
|
|
position:
|
|
CHART-63bEuxjDMJ:
|
|
children: []
|
|
id: CHART-63bEuxjDMJ
|
|
meta:
|
|
chartId: 115
|
|
height: 60
|
|
sliceName: Vaccine Candidates per Country
|
|
sliceNameOverride: Map of Vaccine Candidates
|
|
uuid: ddc91df6-fb40-4826-bdca-16b85af1c024
|
|
width: 8
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-xSeNAspgw
|
|
type: CHART
|
|
CHART-F-fkth0Dnv:
|
|
children: []
|
|
id: CHART-F-fkth0Dnv
|
|
meta:
|
|
chartId: 118
|
|
height: 82
|
|
sliceName: Vaccine Candidates per Country
|
|
sliceNameOverride: Treemap of Vaccine Candidates per Country
|
|
uuid: e2f5a8a7-feb0-4f79-bc6b-01fe55b98b3c
|
|
width: 4
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-dieUdkeUw
|
|
type: CHART
|
|
CHART-RjD_ygqtwH:
|
|
children: []
|
|
id: CHART-RjD_ygqtwH
|
|
meta:
|
|
chartId: 121
|
|
height: 72
|
|
sliceName: Vaccine Candidates per Phase
|
|
sliceNameOverride: Vaccine Candidates per
|
|
uuid: 30b73c65-85e7-455f-bb24-801bb0cdc670
|
|
width: 3
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-zhOlQLQnB
|
|
type: CHART
|
|
CHART-aGfmWtliqA:
|
|
children: []
|
|
id: CHART-aGfmWtliqA
|
|
meta:
|
|
chartId: 119
|
|
height: 72
|
|
sliceName: Vaccine Candidates per Phase
|
|
sliceNameOverride: Vaccine Candidates per
|
|
uuid: 392f293e-0892-4316-bd41-c927b65606a4
|
|
width: 5
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-zhOlQLQnB
|
|
type: CHART
|
|
CHART-dCUpAcPsji:
|
|
children: []
|
|
id: CHART-dCUpAcPsji
|
|
meta:
|
|
chartId: 120
|
|
height: 82
|
|
sliceName: Vaccine Candidates per Country & Stage
|
|
sliceNameOverride: Heatmap of Countries & Clinical Stages
|
|
uuid: cd111331-d286-4258-9020-c7949a109ed2
|
|
width: 4
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-dieUdkeUw
|
|
type: CHART
|
|
CHART-fYo7IyvKZQ:
|
|
children: []
|
|
id: CHART-fYo7IyvKZQ
|
|
meta:
|
|
chartId: 117
|
|
height: 60
|
|
sliceName: Vaccine Candidates per Country & Stage
|
|
sliceNameOverride: Sunburst of Country & Clinical Stages
|
|
uuid: f69c556f-15fe-4a82-a8bb-69d5b6954123
|
|
width: 4
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-xSeNAspgw
|
|
type: CHART
|
|
CHART-j4hUvP5dDD:
|
|
children: []
|
|
id: CHART-j4hUvP5dDD
|
|
meta:
|
|
chartId: 116
|
|
height: 82
|
|
sliceName: Vaccine Candidates per Approach & Stage
|
|
sliceNameOverride: Heatmap of Approaches & Clinical Stages
|
|
uuid: 0c953c84-0c9a-418d-be9f-2894d2a2cee0
|
|
width: 4
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-dieUdkeUw
|
|
type: CHART
|
|
CHART-jaF1vC1uLHuVFdYgd2XLz:
|
|
children: []
|
|
id: CHART-jaF1vC1uLHuVFdYgd2XLz
|
|
meta:
|
|
chartId: 110
|
|
height: 50
|
|
sliceName: Seasonality of Revenue (per Product Line)
|
|
uuid: cf0da099-b3ab-4d94-ab62-cf353ac3c611
|
|
width: 12
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-ajetnVySHMw6olq9m1y89
|
|
type: CHART
|
|
DASHBOARD_VERSION_KEY: v2
|
|
GRID_ID:
|
|
children: []
|
|
id: GRID_ID
|
|
parents:
|
|
- ROOT_ID
|
|
type: GRID
|
|
HEADER_ID:
|
|
id: HEADER_ID
|
|
meta:
|
|
text: COVID Vaccine Dashboard
|
|
type: HEADER
|
|
MARKDOWN-VjQQ5SFj5v:
|
|
children: []
|
|
id: MARKDOWN-VjQQ5SFj5v
|
|
meta:
|
|
code: '# COVID-19 Vaccine Dashboard
|
|
|
|
|
|
Everywhere you look, you see negative news about COVID-19. This is to be expected;
|
|
it''''s been a brutal year and this disease is no joke. This dashboard hopes
|
|
to use visualization to inject some optimism about the coming return to normalcy
|
|
we enjoyed before 2020! There''''s lots to be optimistic about:
|
|
|
|
|
|
- the sheer volume of attempts to fund the R&D needed to produce and bring
|
|
an effective vaccine to market
|
|
|
|
- the large number of countries involved in at least one vaccine candidate
|
|
(and the diversity of economic status of these countries)
|
|
|
|
- the diversity of vaccine approaches taken
|
|
|
|
- the fact that 2 vaccines have already been approved (and a hundreds of thousands
|
|
of patients have already been vaccinated)
|
|
|
|
|
|
### The Dataset
|
|
|
|
|
|
This dashboard is powered by data maintained by the Millken Institute ([link
|
|
to dataset](https://airtable.com/shrSAi6t5WFwqo3GM/tblEzPQS5fnc0FHYR/viwDBH7b6FjmIBX5x?blocks=bipZFzhJ7wHPv7x9z)).
|
|
We researched each vaccine candidate and added our own best guesses for the
|
|
country responsible for each vaccine effort.
|
|
|
|
|
|
_Note that this dataset was last updated on 07/2021_.
|
|
|
|
|
|
'
|
|
height: 72
|
|
width: 4
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
- ROW-zhOlQLQnB
|
|
type: MARKDOWN
|
|
ROOT_ID:
|
|
children:
|
|
- TABS-wUKya7eQ0Z
|
|
id: ROOT_ID
|
|
type: ROOT
|
|
ROW-ajetnVySHMw6olq9m1y89:
|
|
children:
|
|
- CHART-jaF1vC1uLHuVFdYgd2XLz
|
|
id: ROW-ajetnVySHMw6olq9m1y89
|
|
meta:
|
|
background: BACKGROUND_TRANSPARENT
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
type: ROW
|
|
ROW-dieUdkeUw:
|
|
children:
|
|
- CHART-F-fkth0Dnv
|
|
- CHART-dCUpAcPsji
|
|
- CHART-j4hUvP5dDD
|
|
id: ROW-dieUdkeUw
|
|
meta:
|
|
'0': ROOT_ID
|
|
background: BACKGROUND_TRANSPARENT
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
type: ROW
|
|
ROW-xSeNAspgw:
|
|
children:
|
|
- CHART-63bEuxjDMJ
|
|
- CHART-fYo7IyvKZQ
|
|
id: ROW-xSeNAspgw
|
|
meta:
|
|
'0': ROOT_ID
|
|
background: BACKGROUND_TRANSPARENT
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
type: ROW
|
|
ROW-zhOlQLQnB:
|
|
children:
|
|
- MARKDOWN-VjQQ5SFj5v
|
|
- CHART-RjD_ygqtwH
|
|
- CHART-aGfmWtliqA
|
|
id: ROW-zhOlQLQnB
|
|
meta:
|
|
'0': ROOT_ID
|
|
background: BACKGROUND_TRANSPARENT
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
- TAB-BCIJF4NvgQ
|
|
type: ROW
|
|
TAB-BCIJF4NvgQ:
|
|
children:
|
|
- ROW-zhOlQLQnB
|
|
- ROW-xSeNAspgw
|
|
- ROW-dieUdkeUw
|
|
- ROW-ajetnVySHMw6olq9m1y89
|
|
id: TAB-BCIJF4NvgQ
|
|
meta:
|
|
text: Overview
|
|
parents:
|
|
- ROOT_ID
|
|
- TABS-wUKya7eQ0Z
|
|
type: TAB
|
|
TABS-wUKya7eQ0Z:
|
|
children:
|
|
- TAB-BCIJF4NvgQ
|
|
id: TABS-wUKya7eQ0Z
|
|
meta: {}
|
|
parents:
|
|
- ROOT_ID
|
|
type: TABS
|
|
metadata:
|
|
timed_refresh_immune_slices: []
|
|
expanded_slices: {}
|
|
refresh_frequency: 0
|
|
default_filters: '{}'
|
|
native_filter_configuration:
|
|
- id: NATIVE_FILTER-8jS1fx4hl
|
|
controlValues:
|
|
enableEmptyFilter: false
|
|
defaultToFirstItem: false
|
|
multiSelect: true
|
|
searchAllOptions: false
|
|
inverseSelection: false
|
|
name: Country
|
|
filterType: filter_select
|
|
targets:
|
|
- column:
|
|
name: country_name
|
|
datasetUuid: 974b7a1c-22ea-49cb-9214-97b7dbd511e0
|
|
defaultDataMask:
|
|
extraFormData: {}
|
|
filterState: {}
|
|
ownState: {}
|
|
cascadeParentIds: []
|
|
scope:
|
|
rootPath:
|
|
- ROOT_ID
|
|
excluded: []
|
|
type: NATIVE_FILTER
|
|
description: ''
|
|
chartsInScope:
|
|
- 9
|
|
- 10
|
|
- 11
|
|
- 12
|
|
- 13
|
|
- 14
|
|
- 15
|
|
- 66
|
|
tabsInScope:
|
|
- TAB-BCIJF4NvgQ
|
|
- id: NATIVE_FILTER-3_1wEdKkP
|
|
controlValues:
|
|
enableEmptyFilter: false
|
|
defaultToFirstItem: false
|
|
multiSelect: true
|
|
searchAllOptions: false
|
|
inverseSelection: false
|
|
name: Vaccine Approach
|
|
filterType: filter_select
|
|
targets:
|
|
- column:
|
|
name: product_category
|
|
datasetUuid: 974b7a1c-22ea-49cb-9214-97b7dbd511e0
|
|
defaultDataMask:
|
|
extraFormData: {}
|
|
filterState: {}
|
|
ownState: {}
|
|
cascadeParentIds: []
|
|
scope:
|
|
rootPath:
|
|
- ROOT_ID
|
|
excluded: []
|
|
type: NATIVE_FILTER
|
|
description: ''
|
|
chartsInScope:
|
|
- 9
|
|
- 10
|
|
- 11
|
|
- 12
|
|
- 13
|
|
- 14
|
|
- 15
|
|
- 66
|
|
tabsInScope:
|
|
- TAB-BCIJF4NvgQ
|
|
- id: NATIVE_FILTER-EWNH3M70z
|
|
controlValues:
|
|
enableEmptyFilter: false
|
|
defaultToFirstItem: false
|
|
multiSelect: true
|
|
searchAllOptions: false
|
|
inverseSelection: false
|
|
name: Clinical Stage
|
|
filterType: filter_select
|
|
targets:
|
|
- column:
|
|
name: clinical_stage
|
|
datasetUuid: 974b7a1c-22ea-49cb-9214-97b7dbd511e0
|
|
defaultDataMask:
|
|
extraFormData: {}
|
|
filterState: {}
|
|
ownState: {}
|
|
cascadeParentIds: []
|
|
scope:
|
|
rootPath:
|
|
- ROOT_ID
|
|
excluded: []
|
|
type: NATIVE_FILTER
|
|
description: ''
|
|
chartsInScope:
|
|
- 9
|
|
- 10
|
|
- 11
|
|
- 12
|
|
- 13
|
|
- 14
|
|
- 15
|
|
- 66
|
|
tabsInScope:
|
|
- TAB-BCIJF4NvgQ
|
|
color_scheme: supersetColors
|
|
label_colors:
|
|
'0': '#D3B3DA'
|
|
'1': '#9EE5E5'
|
|
0. Pre-clinical: '#1FA8C9'
|
|
2. Phase II or Combined I/II: '#454E7C'
|
|
1. Phase I: '#5AC189'
|
|
3. Phase III: '#FF7F44'
|
|
4. Authorized: '#666666'
|
|
root: '#1FA8C9'
|
|
Protein subunit: '#454E7C'
|
|
Phase II: '#5AC189'
|
|
Pre-clinical: '#FF7F44'
|
|
Phase III: '#666666'
|
|
Phase I: '#E04355'
|
|
Phase I/II: '#FCC700'
|
|
Inactivated virus: '#A868B7'
|
|
Virus-like particle: '#3CCCCB'
|
|
Replicating bacterial vector: '#A38F79'
|
|
DNA-based: '#8FD3E4'
|
|
RNA-based vaccine: '#A1A6BD'
|
|
Authorized: '#ACE1C4'
|
|
Non-replicating viral vector: '#FEC0A1'
|
|
Replicating viral vector: '#B2B2B2'
|
|
Unknown: '#EFA1AA'
|
|
Live attenuated virus: '#FDE380'
|
|
COUNT(*): '#D1C6BC'
|
|
color_scheme_domain:
|
|
- '#1FA8C9'
|
|
- '#454E7C'
|
|
- '#5AC189'
|
|
- '#FF7F44'
|
|
- '#666666'
|
|
- '#E04355'
|
|
- '#FCC700'
|
|
- '#A868B7'
|
|
- '#3CCCCB'
|
|
- '#A38F79'
|
|
- '#8FD3E4'
|
|
- '#A1A6BD'
|
|
- '#ACE1C4'
|
|
- '#FEC0A1'
|
|
- '#B2B2B2'
|
|
- '#EFA1AA'
|
|
- '#FDE380'
|
|
- '#D3B3DA'
|
|
- '#9EE5E5'
|
|
- '#D1C6BC'
|
|
shared_label_colors:
|
|
- 0. Pre-clinical
|
|
- 1. Phase I
|
|
- 2. Phase II or Combined I/II
|
|
- 3. Phase III
|
|
- 4. Authorized
|
|
- <NULL>
|
|
- count
|
|
map_label_colors:
|
|
count: '#1FA8C9'
|
|
<NULL>: '#5AC189'
|
|
Turkey: '#454E7C'
|
|
Nigeria: '#FF7F44'
|
|
Switzerland: '#666666'
|
|
Bangladesh: '#E04355'
|
|
Indonesia: '#FCC700'
|
|
Italy: '#A868B7'
|
|
Russia: '#3CCCCB'
|
|
China: '#A38F79'
|
|
Sweden: '#8FD3E4'
|
|
Netherlands: '#A1A6BD'
|
|
Romania: '#ACE1C4'
|
|
Brazil: '#FEC0A1'
|
|
Chinese Taipei: '#B2B2B2'
|
|
Australia: '#EFA1AA'
|
|
Germany: '#FDE380'
|
|
Canada: '#D3B3DA'
|
|
Finland: '#9EE5E5'
|
|
South Korea: '#D1C6BC'
|
|
Argentina: '#9EE5E5'
|
|
Spain: '#D1C6BC'
|
|
Cuba: '#454E7C'
|
|
Slovenia: '#5AC189'
|
|
Egypt: '#FF7F44'
|
|
India: '#666666'
|
|
Iran: '#E04355'
|
|
Belgium: '#FCC700'
|
|
Chile: '#A868B7'
|
|
France: '#3CCCCB'
|
|
Vietnam: '#A38F79'
|
|
Slovakia: '#8FD3E4'
|
|
Israel: '#A1A6BD'
|
|
Peru: '#ACE1C4'
|
|
Kazakhstan: '#FEC0A1'
|
|
Japan: '#B2B2B2'
|
|
Great Britain: '#EFA1AA'
|
|
Denmark: '#FDE380'
|
|
Thailand: '#D3B3DA'
|
|
United States: '#D3B3DA'
|
|
chart_configuration:
|
|
'115':
|
|
id: 115
|
|
crossFilters:
|
|
scope: global
|
|
chartsInScope:
|
|
- 110
|
|
- 116
|
|
- 117
|
|
- 118
|
|
- 119
|
|
- 120
|
|
- 121
|
|
'117':
|
|
id: 117
|
|
crossFilters:
|
|
scope: global
|
|
chartsInScope:
|
|
- 110
|
|
- 115
|
|
- 116
|
|
- 118
|
|
- 119
|
|
- 120
|
|
- 121
|
|
'118':
|
|
id: 118
|
|
crossFilters:
|
|
scope: global
|
|
chartsInScope:
|
|
- 110
|
|
- 115
|
|
- 116
|
|
- 117
|
|
- 119
|
|
- 120
|
|
- 121
|
|
'119':
|
|
id: 119
|
|
crossFilters:
|
|
scope: global
|
|
chartsInScope:
|
|
- 110
|
|
- 115
|
|
- 116
|
|
- 117
|
|
- 118
|
|
- 120
|
|
- 121
|
|
'121':
|
|
id: 121
|
|
crossFilters:
|
|
scope: global
|
|
chartsInScope:
|
|
- 110
|
|
- 115
|
|
- 116
|
|
- 117
|
|
- 118
|
|
- 119
|
|
- 120
|
|
global_chart_configuration:
|
|
scope:
|
|
rootPath:
|
|
- ROOT_ID
|
|
excluded: []
|
|
chartsInScope:
|
|
- 110
|
|
- 115
|
|
- 116
|
|
- 117
|
|
- 118
|
|
- 119
|
|
- 120
|
|
- 121
|
|
cross_filters_enabled: true
|
|
theme_uuid: null
|
|
version: 1.0.0
|